findmyKOL

Justin Muste, MD

Basic profile

Ophthalmology

ORCIDNPI
RegionPhiladelphia, PA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Justin Muste is an Ophthalmology physician. OpenAlex indexes 81 publications with 439 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
81publications

Distinct works indexed by OpenAlex, matched via ORCID.

439citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

840 Walnut St Ste 1020
Philadelphia, PA 191075109

Telephone

800-331-6634

Provider last certified this registry record 23 Jun 2025.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    82.9%
    Prostaglandin Analog36.6%
    Latanoprost96%Lumigan5%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor20.6%
    Dorzolamide-Timolol79%Dorzolamide Hcl21%
    Part D117 patients

    + 4 more classes in this area

  • Cardiovascular

    7.1%
    Beta blocker7.1%
    Timolol Maleate100%
    Part D53 patients
  • Cancer & immunology

    3.5%
    Calcineurin inhibitor2.6%
    Restasis100%
    Part D14 patients
    Vascular Endothelial Growth Factor Inhibitor0.9%
    Eylea100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”